Detalhe da pesquisa
1.
Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.
PLoS Pathog
; 20(1): e1011881, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38190392
2.
Characterization of treatment resistance and viral kinetics in the setting of single- versus dual-active monoclonal antibodies against SARS-CoV-2.
J Infect Dis
; 2024 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38716969
3.
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
Ann Intern Med
; 176(3): 348-354, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36802755
4.
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Ann Intern Med
; 176(5): 658-666, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37068272
5.
Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy.
J Infect Dis
; 228(1): 64-69, 2023 06 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36881933
6.
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
J Infect Dis
; 228(Suppl 2): S77-S82, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650231
7.
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
J Infect Dis
; 228(Suppl 2): S92-S100, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650234
8.
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
J Infect Dis
; 228(Suppl 2): S83-S91, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650237
9.
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.
J Infect Dis
; 228(2): 133-142, 2023 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36661240
10.
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
J Infect Dis
; 228(Suppl 2): S117-S125, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650230
11.
Variant-Specific Viral Kinetics in Acute COVID-19.
J Infect Dis
; 228(Suppl 2): S136-S143, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650233
12.
Immune Status and SARS-CoV-2 Viral Dynamics.
J Infect Dis
; 228(Suppl 2): S111-S116, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650232
13.
Long COVID After Bamlanivimab Treatment.
J Infect Dis
; 228(Suppl 2): S126-S135, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650236
14.
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.
J Infect Dis
; 228(Suppl 2): S101-S110, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37650235
15.
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019.
Clin Infect Dis
; 76(4): 734-737, 2023 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36210483
16.
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.
Clin Infect Dis
; 77(7): 941-949, 2023 10 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37279602
17.
Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260s.
Clin Infect Dis
; 74(5): 857-864, 2022 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34117756
18.
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus.
Clin Infect Dis
; 74(1): 95-104, 2022 01 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33693561
19.
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
N Engl J Med
; 390(16): 1533-1534, 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38657253
20.
Antiretroviral Therapy Initiation Is Associated With Decreased Visceral and Subcutaneous Adipose Tissue Density in People Living With Human Immunodeficiency Virus.
Clin Infect Dis
; 72(6): 979-986, 2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32107532